Evidence mapPaperPMID 42511513Full record

ReviewInternational journal of molecular sciences2026

Goldenhar Syndrome-Embryological, Anatomical, Etiopathogenic Mechanisms and Treatment of Obstructive Sleep Apnea.

Katarzyna Sluzalec-Wieckiewicz, Edward Kijak, Irena Dus-Ilnicka, Marcin Mikulewicz, Joanna Laskowska, Piotr Seweryn, Conrad Maslowiec, Lucia Miralles-Jorda, Marta Mazur, Anna Paradowska-Stolarz

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katarzyna Sluzalec-WieckiewiczDepartment of Prosthodontics, Wrocław Medical University, ul. Krakowska 26, 50425 Wroclaw, Poland.
Edward KijakDepartment of Prosthodontics, Wrocław Medical University, ul. Krakowska 26, 50425 Wroclaw, Poland.ORCID 0000-0003-4110-5987
Irena Dus-IlnickaDivision of General and Experimental Pathology, Department of Clinical and Experimental Pathology, Wroclaw Medical University, ul. T. Marcinkowskiego 1, 50-368 Wroclaw, Poland.ORCID 0000-0002-4745-2560
Marcin MikulewiczDivision of Facial Abnormalities, Department of Maxillofacial Orthopedics and Orthodontics, Faculty of Dentistry, Wroclaw Medical University, Krakowska 26, 50-425 Wroclaw, Poland.ORCID 0000-0001-5754-0284
Joanna LaskowskaDivision of Facial Abnormalities, Department of Maxillofacial Orthopedics and Orthodontics, Faculty of Dentistry, Wroclaw Medical University, Krakowska 26, 50-425 Wroclaw, Poland.ORCID 0000-0001-9207-9067
Piotr SewerynDepartment of Experimental Dentistry, Wroclaw Medical University, Krakowska 26, 50-425 Wroclaw, Poland.
Conrad MaslowiecUniversity Dental Center, Krakowska 26, 50-425 Wroclaw, Poland.
Lucia Miralles-JordaDepartment of Dentistry, Catholic University of Valencia, Quevedo Str. 2, 46001 Valencia, Spain.ORCID 0000-0002-0424-9861
Marta MazurInterdisciplinary Department of Wellbeing, Health and Environmental Sustainability-BeSSA Department, Sapienza University of Rome, 02100 Rieti, Italy.ORCID 0000-0002-0525-681X
Anna Paradowska-StolarzDivision of Facial Abnormalities, Department of Maxillofacial Orthopedics and Orthodontics, Faculty of Dentistry, Wroclaw Medical University, Krakowska 26, 50-425 Wroclaw, Poland.ORCID 0000-0003-2817-1445

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Goldenhar syndrome is a developmental defect of the 1st and 2nd brachial arches. Facial asymmetry and ear-eye abnormalities are observed. Frequent presence of concomitant issues, including severe OSA (obstructive sleep apnea) and sialorrhea, have also been recorded. The presentation of Goldenhar syndrome is highly variable, and treatment procedures also differ, with surgical treatment often being mandatory. Common symptoms of OSA include loud snoring, gasping, and morning headaches. If untreated, it may lead to high blood pressure, hyperinsulinemia, heart problems, stroke, and daytime sleepiness. Its etiology in Goldenhar syndrome is primarily anatomical and multifactorial. The most common treatment options are based on surgical procedures. Continuous positive airway pressure (CPAP) could be considered for use in individuals with Goldenhar syndrome. Mandibular advancement is a standard procedure for relieving the symptoms of OSA. In general, mandibular advancement would reduce apnea and hypopnea. Another method of managing OSA is hypoglossal nerve stimulation (HNS). Adenotonsillectomy is often the first-line surgical treatment for OSA but it is rarely curative in Goldenhar patients due to underlying skeletal issues. In contrast to American Academy of Sleep Science recommendations of managing OSA, in patients with congenital syndromes, surgical intervention seems to be the most optimal method of treatment.

Indexed as

Goldenhar SyndromeSleep Apnea, ObstructiveContinuous Positive Airway PressureHumans22q chromosomebreathing disordercongenital disorderGoldenhar syndromeobstructive sleep apneaocular–auricular–vertebral syndromeOSA

Identifiers

PMID42511513
PMCPMC13411227

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.